In the United States, supplements are regulated by the FDA as food products rather than drugs
FEBS Lett (1987) 211(2):16974
In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group
171 There exists uncertainty regarding the underlying mechanism for the formation of aggNETs that requires clarification
NHSs Eligibility Criteria details that patients must have a BMI over 40 and must also be diagnosed with a weight-related health condition (such as type 2 diabetes, or hypertension)
NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONISTS, CARDIOVASCULAR AND KIDNEY PROTECTION IN PATIENTS WITH T2DM SGLT2 inhibitors, GLP-1 receptor agonists and non-steroidal MRAs are expected to be increasingly used together in the setting of DKD on a background of single agent RAAS blockade
